Apatinib in patients with extensivestage smallcell lung cancer after secondline or thirdline chemotherapy a phase II singlearm multicentre prospective study

Apatinib in patients with extensive-stage small-cell lung cancer after second-line or third-line chemotherapy: a phase II, single-arm, multicentre, prospective study

21:39 EDT 15 Sep 2019 | Nature Publishing

More From BioPortfolio on "Apatinib in patients with extensive-stage small-cell lung cancer after second-line or third-line chemotherapy: a phase II, single-arm, multicentre, prospective study"